Data / Form D filings / EOLO USA, Inc.
EOLO USA, Inc.: Form D filings
EOLO USA, Inc., a biotechnology company in Wilmington, DE, filed 2 Form D notices with the SEC in 2023. The latest, on February 14, 2023, reports $1.8 million sold of a $3 million offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1209 ORANGE STREET, Wilmington, DE, 19801
- Phone
- (786) 871-3950
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2019
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1961558
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Feb 14, 2023 | Amendment | $2,999,999 | $1,799,999 | $1,200,000 | 9 | Sep 7, 2022 | sec.gov |
| Feb 8, 2023 | New notice | $2,999,999 | $1,799,999 | $1,200,000 | 9 | Sep 7, 2022 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Nicolas Tognalli Tognalli | Director | |
| Carlos Jose Escande | Executive Officer | |
| Paul Tognalli Elberse | Director | |
| Maria Pia Garat | Executive Officer, Director, Promoter | |
| Roland Tognalli Haag | Director |
Other biotechnology companies in Delaware that filed recently
- TCM Life Science Inc. $16,666 · Oct 26, 2026
- Amplica Bio, Inc. $30,000 · Sep 11, 2026
Every Form D from the week of Feb 13, 2023 · All recent filings in Delaware · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what EOLO USA, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.